RVNC announcements Revance Therapeutics, Inc. announcements and dividends declared USA

Revance Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Revance Therapeutics, Inc. RVNC

Revance Therapeutics, Inc. RVNC listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Revance Therapeutics, Inc. RVNC

Goldman Sachs Maintains Revance Therapeutics (RVNC) Buy Recommendation
Fintel reports that on September 21, 2023, Goldman Sachs maintained coverage of Revance Therapeutics (NASDAQ:RVNC) with a Buy recommendation.
Announcement as on 21 September 2023

Revance Therapeutics, Inc. (RVNC) Soars 8.6%: Is Further Upside Left in the Stock?
Revance Therapeutics, Inc. RVNC shares rallied 8.6% in the last trading session to close at .70. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 48% gain
Announcement as on 23 January 2023

Revance Therapeutics, Inc. (RVNC) Reports Q3 Loss, Tops Revenue Estimates
Revance Therapeutics, Inc. (RVNC) came out with a quarterly loss of .17 per share versus the Zacks Consensus Estimate of a loss of [CO].85. This compares to loss of .10 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 08 November 2022

Strength Seen in Revance Therapeutics, Inc. (RVNC): Can Its 8.7% Jump Turn into More Strength?
Revance Therapeutics, Inc. RVNC shares ended the last trading session 8.7% higher at .06. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 34.9% gain over the p
Announcement as on 22 March 2022

Revance Therapeutics plummets after FDA said it can't approve BLA of treatment for frown lines
Shares of Revance Therapeutics Inc. plummeted 34.7% toward an 18-month low in premarket Monday, which puts them on track for a record one-day selloff, after the company said the the Food and Drug Administration issued a Complete Response Letter (CRL) rega
Announcement as on 18 October 2021

Announcements by Revance Therapeutics, Inc. first page | Next page |

RVNC Revance Therapeutics, Inc. current price & indicator signals

Moving Averages for Revance Therapeutics, Inc.

  • 5Day Average: 3.64
  • 12Day Average: 3.65
  • 20Day Average: 3.54
  • 50Day Average: 3.41
  • 100Day Average: 4.41
  • 150Day Average: 4.52
  • 200Day Average: 4.18

RVNC Indicators & signals

Indicator MACD (12,26,9)

3.61, 3.54, 0.05
Indicator MACD is in positive zone

Indicator ADX (14)

0, 87.5, 87.5
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RVNC Revance Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Wed Feb 2025 3.65 3.65 to 3.66 0.27% 1.75 times
04 Tue Feb 2025 3.64 3.63 to 3.65 0% 0.9 times
03 Mon Feb 2025 3.64 3.63 to 3.64 0.28% 0.3 times
31 Fri Jan 2025 3.63 3.62 to 3.65 0% 1.53 times
30 Thu Jan 2025 3.63 3.62 to 3.66 -0.27% 3.47 times
29 Wed Jan 2025 3.64 3.64 to 3.66 -0.27% 0.39 times
28 Tue Jan 2025 3.65 3.64 to 3.66 0.27% 0.68 times
27 Mon Jan 2025 3.64 3.64 to 3.67 -0.27% 0.59 times
24 Fri Jan 2025 3.65 3.65 to 3.69 -0.54% 0.28 times
23 Thu Jan 2025 3.67 3.64 to 3.69 0.55% 0.5 times
22 Wed Jan 2025 3.65 3.62 to 3.68 -0.54% 1.35 times
21 Tue Jan 2025 3.67 3.64 to 3.67 -0.27% 2.35 times

Videos related to: RVNC announcements Revance Therapeutics, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RVNC announcements Revance Therapeutics, Inc. announcements and dividends declared USA

 

Back to top